Scientific Officer Lan SUNG - CUHK Research Portal - CONVERIS Research Information System

Go to Header Go to Navigation Go to Content Go to Footer

Dr SUNG Lan

Personal Information

Position and Department

Scientific Officer, Hong Kong Cancer Institute

CUHK Research Outputs

Silencing of hypoxia-inducible tumor suppressor lysyl oxidase gene by promoter methylation activates carbonic anhydrase IX in nasopharyngeal carcinoma (2014)

Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activation (2011)

The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines (2010)

Hypoxia-targeting by Tirapazamine (TPZ) Induces Preferential Antitumor Effects in Nasopharyngeal Cancer under Hypoxia (2008)

Plasma Osteopontin, Hypoxia, and Response to Radiotherapy in Nasopharyngeal Cancer (2008)

Pharmacologic demethylation identifies UCHL1 as a tumor suppressor gene frequently silenced in nasopharyngeal and multiple other carcinomas (2007)

The effect of the histone deacetylase inhibitor (HDACi) PXD101 on cell growth and expression of viral and host genes in hepatitis B virus (HBV)-carrying hepatocellular carcinoma (HCC) cell lines (2007)

Pharmacoproteomics study of cetuximab in nasopharyngeal carcinoma (2006)

Antitumor effect and enhancement of cytotoxic drug activity by cetuximab in nasopharyngeal carcinoma cells (2005)

Hypoxia Induces Hypoxia-Inducible Factor (HIF)-1 alpha and Carbonic Anhydrase (CA) IX in Nasopharyngeal Carcinoma Cell Lines Through Difference Mechanisms (2005)

Cetuximab induced changes in cell proliferation- and apoptosis-associated proteins of nasopharyngeal carcinoma - a proteomic study (2004)